Connection
Jeffrey Goldstein to Enzyme Inhibitors
This is a "connection" page, showing publications Jeffrey Goldstein has written about Enzyme Inhibitors.
|
|
Connection Strength |
|
|
|
|
|
0.009 |
|
|
|
-
Karam WG, Goldstein JA, Lasker JM, Ghanayem BI. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes. Drug Metab Dispos. 1996 Oct; 24(10):1081-7.
Score: 0.009